Response to "tissue-engineered airway in the clinical setting: A call for information disclosure"

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 6, 2012, Pages 974-

  MacChiarini, P ^a   Jungebluth, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY; CELL CULTURE; LETTER; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84861347177     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.52     Document Type: Letter

References (5)

1. Wurtz, A. & Kipnis, E. Tissue-engineered airway in the clinical setting: a call for information disclosure. Clin. Pharmacol. Ther., 91, 973 (2012).
2. Wurtz, A. et al. Tracheal replacement with aortic allografts. N. Engl. J. Med. 355, 1938-1940 (2006).
3. Wurtz, A. et al. Surgical technique and results of tracheal and carinal replacement with aortic allografts for salivary gland-type carcinoma. J. Thorac. Cardiovasc. Surg. 140, 387-393.e2 (2010).
4. Bader, A. & Macchiarini, P. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J. Cell. Mol. Med. 14, 1877-1889 (2010).
5. J ungebluth, P. et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 378, 1997-2004 (2011).